To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
633 Newest Market Studies
rss
Key Companies: HIV - Companies co-operate and co-formulate to stay competitive in a tight HIV market
Introduction HIV across the seven major markets is largely dominated by two companies: Gilead Sciences and ViiV Healthcare. The growing dominance of convenient one-pill once-daily regimens will increasingly pressure companies to collaborate and co-formulate their marketed and/or pipeline HIV ...
F. Hoffmann-La Roche Ltd: PharmaVitae Profile
Introduction This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key ...
Prescribing Influences: Alzheimer's Disease - Alleviating symptoms remains the goal for prescribers
Introduction Datamonitor conducted a survey of neurologists to ascertain the perceived level of unmet need in Alzheimer’s disease and to assess which factors have the greatest influence...
Product Profiles: Depression - Next generation vies for second-line patients
Datamonitor’s independent appraisal of marketed brands and key pipeline agents indicated for treating depression. * Illustrate how pipeline and marketed drugs compare to one another in terms of clinical...
R&D Trends: Prostate Cancer - Newly approved therapies shift treatment dynamics for castrate-resistant disease
Introduction The late-phase prostate cancer pipeline is dominated by targeted therapies, closely followed by immunotherapies. There are a growing number of therapies with novel targets such as Zibotentan (AstraZeneca) which targets endothelin-A (ET-A). Identification of the correct molecular ...
Product Profiles: Osteoporosis - Novel candidates offer the greatest potential
* Understand Datamonitor’s independent appraisal of marketed brands and key pipeline agents indicated for treating osteoporosis * Illustrate how pipeline and marketed drugs compare to one another in terms...
Epidemiology: Diabetes in Australia - Despite government efforts to promote healthy lifestyles, the number of cases of diabetes in Australia is set to soar
in Australia Highlights Datamonitor estimates that there will be a marginal increase in the incidence of cases of type 1 diabetes in children under the age of 14 in Australia between 2010 and 2020. Datamonitor...
Hot Topics in Type 2 Diabetes: Physician Perceptions of Insulin - Physician survey provides insights into insulin usage and needs
Introduction Insulin prescribing practices and physician perception of unmet needs vary widely among the seven major markets. Datamonitor surveyed 199 primary care physicians and specialists across...
Product Profiles: Multiple Sclerosis - Gilenya raises bar for new market entrants
and benefits * Understand Datamonitor’s independent appraisal of marketed brands and key pipeline agents indicated for treating multiple sclerosis. * Illustrate how pipeline and marketed drugs compare to one...
R&D Trends: Attention-Deficit Hyperactivity Disorder - Growing pipeline indicates a trend towards adjunctive and adult therapy
and benefits * Understand key R&D dynamics in the pipeline for new ADHD therapies. * Benchmark novel and existing therapies using the target product profile identified by Datamonitor. * Support R&D decision...
Netmeeting
